
Reimbursement approval gets a medicine onto the Greek positive list. It does not get it into a public hospital. That last step runs through a[…]

Quality risk management has been a GMP expectation since 2006, but the revised ICH Q9(R1) — effective in the EU since 26 July 2023 —[…]

Product information for a veterinary medicine has to work for readers who are not clinicians. A farmer calculating a dose for a group of animals,[…]

A veterinary pharmacovigilance inspection is not a document review. It is an attempt to establish whether the system described on paper is the system that[…]

A veterinary medicine can be manufactured under impeccable conditions and still reach the animal in an unusable state. Regulation (EU) 2019/6 places distribution under its[…]

Every marketing authorisation holder with veterinary products needs a qualified person responsible for pharmacovigilance. The role is easy to fill badly: a name entered on[…]

Veterinary medicines reach the environment by routes that human medicines largely do not: through manure spread on land, through direct excretion at pasture, through aquaculture[…]

The technical content of a veterinary marketing authorisation application is governed by Annex II to Regulation (EU) 2019/6, as replaced by Commission Delegated Regulation (EU)[…]

Companies bringing a veterinary product into Greece often assume the process mirrors the human medicines pathway they already know. Much of it does. The National[…]

Retail of veterinary medicinal products at a distance is permitted across the EU, but on defined terms. Article 104 of Regulation (EU) 2019/6 sets the[…]